Arvinas (ARVN) Net Margin (2017 - 2026)

Arvinas' (ARVN) quarterly Net Margin came in at 369.23% in Q1 2026, down 41314.0% year-on-year from N/an in Q1 2025, and up 47.96% quarter-over-quarter from 709.47% in Q4 2025.

Arvinas (ARVN) Net Margin (2017 - 2026) Analysis & Trends

Arvinas' Net Margin history runs 10 years deep, the most recent figure standing at 369.23% for Q1 2026.

  • On a quarterly basis, Net Margin fell 41314.0% year-over-year to 369.23% in Q1 2026; TTM through Mar 2026 was 247.54%, a 23662.0% decrease from a year earlier, with the FY2025 full-year figure at 30.77%, up 4474.0% from the prior year.
  • Net Margin advanced to 369.23% in Q1 2026 per ARVN's latest filing, from 709.47% in the prior quarter.
  • Across five years, Net Margin topped out at 359.16% in Q4 2023 and bottomed at 709.47% in Q4 2025.
  • The 5-year median for Net Margin is 190.66% (2022), against an average of 168.42%.
  • Across the five-year window, Net Margin soared 71484 bps in 2022 and tumbled 63329 bps in 2025, its largest moves.
  • Year by year, Net Margin stood at 211.9% in 2022, then jumped by 269 bps to 359.16% in 2023, then slumped by 121 bps to 76.18% in 2024, then plunged by 831 bps to 709.47% in 2025, then jumped by 48 bps to 369.23% in 2026.
  • Per Business Quant, the three latest ARVN Net Margin figures stand at 369.23% (Q1 2026), 709.47% (Q4 2025), and 83.77% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Arvinas 519.68 Mn -95.22 Mn - -369.23%

Historic Data

Download Data
DateValue
Mar 31, 2026 -369.23%
Dec 31, 2025 -709.47%
Sep 30, 2025 -83.77%
Jun 30, 2025 -273.21%
Mar 31, 2025 43.91%
Dec 31, 2024 -76.18%
Sep 30, 2024 -48.05%
Jun 30, 2024 -46.01%
Mar 31, 2024 -274.31%
Dec 31, 2023 359.16%
Sep 30, 2023 -184.68%
Jun 30, 2023 -119.82%
Mar 31, 2023 -248.62%
Dec 31, 2022 -211.90%
Sep 30, 2022 -190.66%
Jun 30, 2022 -199.70%
Mar 31, 2022 -230.57%
Dec 31, 2021 -138.86%
Sep 30, 2021 -503.23%
Jun 30, 2021 -914.55%